Clinical Trial Update: Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial investigates autologous dendritic cells loaded with oncofetal antigen/iLRP for metastatic breast cancer. The sponsor is Quantum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Autologous dendritic cell therapy loaded with oncofetal antigen/iLRP

Snippet

Sponsor: Quantum Immunologics, Inc. | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN